
Yingzhe Wang
Articles
-
Apr 25, 2024 |
nature.com | Matthew Rees |Melissa Ronan |Jennifer Roth |Yingzhe Wang |Brent A. Orr |Brian J. Abraham | +3 more
AbstractChemical discovery efforts commonly target individual protein domains. Many proteins, including the EP300/CBP histone acetyltransferases (HATs), contain several targetable domains. EP300/CBP are critical gene-regulatory targets in cancer, with existing high potency inhibitors of either the catalytic HAT domain or protein-binding bromodomain (BRD).
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →